Role of intracellular interleukin-1 receptor antagonist in skin carcinogenesis

Molecular Carcinogenesis

Volumn 30, Issue 4, 2001, Pages 218-223

  La, Eunhye ^a   Rundhaug, Joyce E ^a   Fischer, Susan M ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

Cell growth; Intracellular interleukin 1 receptor antagonist; Skin

Indexed keywords

CYCLOOXYGENASE 2; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; MESSENGER RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER INHIBITION; CARCINOMA CELL; CELL COUNT; CELL PROLIFERATION; CONTROLLED STUDY; FEMALE; GENETIC TRANSFECTION; INFLAMMATION; MOUSE; NONHUMAN; PLEIOTROPY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKIN CARCINOGENESIS; SKIN CARCINOMA; TRANSCRIPTION REGULATION; TUMOR VOLUME;

ANIMALS; BLOTTING, NORTHERN; CARCINOGENICITY TESTS; CARCINOMA, SQUAMOUS CELL; CELL DIVISION; CYCLOOXYGENASE 2; FEMALE; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; ISOENZYMES; KERATINOCYTES; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; SIALOGLYCOPROTEINS; SKIN NEOPLASMS; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0035035993     PISSN: 08991987     EISSN: None     Source Type: Journal    
DOI: 10.1002/mc.1031     Document Type: Article

References (39)

1. Interleukin 1 and interleukin 1 antagonism
2. Biological basis for interleukin 1 in diseases
3. Interleukin 1 receptor antagonist: Discovery, structure and properties
4. Interleukin 1 receptor antagonist: Role in biology
5. Functions of interleukin 1 receptor antagonist in gene knockout and overproducing mice
6. Altered susceptibility to collagen-induced arthritis in transgenic mice with aberrant expression of interleukin 1 receptor antagonist
7. The interleukin 1 family: 10 years of discovery
8. Differential expression of interleukin 1 receptor antagonist isoform in human intestinal epithelial cells
9. Interleukin 1 receptor antagonist inhibits interleukin 8 expression in A549 respiratory epithelial cells infected in vitro with a replication-deficient recombinant adenovirus vector
10. Regulation of prostaglandin production in intact fetal membrane by interleukin 1 and its receptor antagonist
11. Characterization of type II intracellular interleukin 1 receptor antagonist: A depot interleukin 1 receptor antagonist
12. Expression of interleukin 1 and interleukin 1 receptor antagonist in endometrial cancer
13. The production of interleukin 1 receptor antagonist by human bronchogenic carcinoma
14. Autocrine interleukin 1 receptor antagonist can support malignant growth of glioblastoma by blocking growth-inhibiting autocrine loop of interleukin 1
15. Interleukin 1 receptor antagonist mRNA expression and the progression of gastric carcinoma
16. Altered expression of interleukin 1 receptor antagonist in different stages of mouse skin carcinogenesis
17. Modular ion of interleukin 1α mRNA expression in mouse epidermis by tumor promoters and antagonists
18. Inflammatory and hyperproliferative skin disease in mice that express elevated levels of the IL-1 receptor (type I) on epidermal keratinocytes
19. In vivo behavior of murine epidermal cell line cerived from initiated and non-initiated skin
20. Mouse interleukin 1 receptor antagonist isoforms: cDNA cloning and protein expression of intracellular form and tissue distribution of secretory and intracellular interleukin 1 receptor antagonist in vivo
21. Modulation of myelopoesis by prostagland n E2: Demonstration of novel mechanism of action in vivo
22. Prostaglandin H synthase 2 is expressed abnormally in human colon cancer: Evidence for transcriptional effect
23. Epidermal cell cycle and transit times during hyperplastic growth induced by abrasion or treatment with 12-O-tetradecanoylphorbol-13-acetate
24. Effects of the phorbol ester TPA and of the ionophore A23187 on phospholipase A2, and C activities in the mouse epidermal cell line: HEL30
25. Transcriptional regulation of cyclooxygenase 2 in mouse skin carcinoma cells
26. Down regulation of cyclooxygenase 2 by interleukin 1 receptor antagonist in human monocytes
27. Differential regulation of cyclooxygenase 1 and 2 by interleukin 1 beta, tumor necrosis factor alpha, and transforming growth factor beta 1 in human lung fibroblast
28. Cyclooxygenase 2 regulates angiogenesis induced by colon cancer cells
29. Selected eicosanoids increase the proliferation rate of human colon carcinoma cell lines and mouse colonocytes in vivo
30. Alteration in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase
31. Interleukin 1 receptor antagonist inhibits augmentation of metastasis induced by interleukin 1 or lipopolysaccharide in a human melanoma/nude mouse system
32. An interleukin 1 receptor antagonist blocks the IL-1 induced IL-6 paracrine production through a prostaglandin F2-related mechanism in multiple myetoma
33. Interleukin 1 dependent melanoma hepatic metastasis in vivo; increased endothelial adherence by IL-1 induced mannose receptors and growth factor production in vitro
34. High intracellular interleukin 1 receptor antagonist levels are correlated with Iow expression of intercellular adhesion molecule-1 in keratinocytes and fibroblasts
35. Suppression of chronic myelogenous leukemia colony growth by interleukin-1 (IL-1) receptor antagonist and soluble IL-1 receptors: A novel application of inhibitors of IL-1 activity
36. cDNA cloning of an intracellular form of the human interleukin 1 receptor antagonist associated with epithelium
37. IL-1 and its receptor are translocated to the nucleus
38. Multifactorial induction of gene expression and nuclear localization of mouse interleukin 1α
39. The N-terminal propiece of interleukin 1α is a transforming nuclear oncoprotein